mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |